Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins - Monthly Prescribing Reference

Notice: WP_Scripts::localize was called incorrectly. The $l10n parameter must be an array. To pass arbitrary data to scripts, use the wp_add_inline_script() function instead. Please see Debugging in WordPress for more information. (This message was added in version 5.7.0.) in /home/cp031225/public_html/cac-hub.com/wp-includes/functions.php on line 5663

Main Menu

Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins - Monthly Prescribing Reference

July 8, 2020 cac

A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.

SOURCE: Empr.com